Defending Affordable Prescription Drug Costs Act
Insurers, pharmacy benefit managers and other payers may not pay a 340B entity less for 340B drugs, set different terms or fees, require a 340B marker on a claim or keep it out of a network. A manufacturer or distributor may not deny, restrict or interfere with a 340B drug reaching a pharmacy under contract with a 340B entity.
- In the code
- La. R.S. 40:2881 through 2886
- Bill
- HB 548
- Act
- Act 358 of 2023
- Session
- 2023
- In effect
- 1 August 2023
- Applies to
- Health insurers, pharmacy benefit managers and other third-party payers; drug manufacturers and distributors
- Limits
- Does not apply to Louisiana Medicaid as payer. Limited distribution required by 21 U.S.C. 355-1 is allowed.
- Enforcement
- A breach is a violation of the Unfair Trade Practices and Consumer Protection Law. There is no private right of action.
Reimburse a 340B entity for 340B drugs at a rate lower than that paid for the same drug to entities that are not 340B entities or lower reimbursement for a claim on the basis that the claim is for a 340B drug